volume 24, issue s2, P143-152 2011
DOI: 10.3233/jad-2011-110269
View full text
|
Sign up to set email alerts
|
Share

Abstract: β-secretase, a key enzyme involved in amyloid-β generation, is an attractive candidate for Alzheimer's disease therapy. Transition-state inhibitors of β-secretase are designed to achieve specificity. However, these inhibitors bind only to the active conformation of the enzyme and as the active β-secretase is sequestered in subcellular compartments, new strategies have to be implemented. We propose that membrane-anchoring of β-secretase inhibitors would render them endocytosis-competent thereby enabling the inh…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

2
5
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals